Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AL B BENSON

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1891761532
CMS profile
1128985
Location
CHICAGO, IL

General Payments · PY2018–2024

$160,764.71

  • Reported across 159 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,360.19

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $28,417.50 8
Travel and Lodging $2,341.37 10
Food and Beverage $601.32 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $11,805.72 6
Incyte Corporation $6,664.72 10
Delcath Systems $3,000.00 1
JAZZ PHARMACEUTICALS INC. $2,450.00 1
TAIHO ONCOLOGY, INC. $2,340.00 1
Merck Sharp & Dohme Corporation $2,285.00 2
GlaxoSmithKline, LLC. $1,767.44 3
Amgen Inc. $962.50 1
Acerta Pharma LLC $84.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $23,694.23 39
PY2019 $35,084.78 38
PY2020 $16,893.88 21
PY2021 $18,045.00 9
PY2022 $12,033.00 11
PY2023 $23,653.63 15
PY2024 $31,360.19 26

Payment records · PY2024 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $962.50 01/04/2024 Consulting Fee Undisputed 01/23/2026 1117202014 CMS
AstraZeneca Pharmaceuticals LP $84.81 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105716146 CMS
Delcath Systems $3,000.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1130859246 CMS
GlaxoSmithKline, LLC. $71.52 05/31/2024 Food and Beverage Undisputed 01/23/2026 1115994791 CMS
GlaxoSmithKline, LLC. $95.92 05/31/2024 Food and Beverage Undisputed 01/23/2026 1116003544 CMS
GlaxoSmithKline, LLC. $1,600.00 07/02/2024 Consulting Fee Undisputed 01/23/2026 1116217621 CMS
Incyte Corporation $41.25 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169185 CMS
Incyte Corporation $291.96 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169195 CMS
Incyte Corporation $137.17 11/21/2024 Food and Beverage Undisputed 01/23/2026 1141169487 CMS
Incyte Corporation $56.00 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141168655 CMS
Incyte Corporation $46.48 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141169183 CMS
Incyte Corporation $499.96 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141169187 CMS
Incyte Corporation $60.00 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169189 CMS
Incyte Corporation $5,480.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1141169197 CMS
Incyte Corporation $26.99 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169489 CMS
Incyte Corporation $24.91 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141170433 CMS
JAZZ PHARMACEUTICALS INC. $2,450.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1150237058 CMS
Merck Sharp & Dohme LLC $2,135.00 06/19/2024 Consulting Fee Undisputed 01/23/2026 1141590614 CMS
Merck Sharp & Dohme LLC $150.00 06/19/2024 Travel and Lodging Undisputed 01/23/2026 1141590616 CMS
TAIHO ONCOLOGY, INC. $2,340.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137939408 CMS
Takeda Pharmaceuticals U.S.A., Inc. $100.00 08/02/2024 Food and Beverage Undisputed 01/23/2026 1144953645 CMS
Takeda Pharmaceuticals U.S.A., Inc. $762.06 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144953647 CMS
Takeda Pharmaceuticals U.S.A., Inc. $199.50 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144953649 CMS
Takeda Pharmaceuticals U.S.A., Inc. $207.32 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144953651 CMS
Takeda Pharmaceuticals U.S.A., Inc. $86.84 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144953653 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10,450.00 09/03/2024 Consulting Fee Undisputed 01/23/2026 1144953655 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.